| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by GCS.
Page 4: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 901 | 1 | 2 | 949 1987 PRENATAL DIAGNOSIS 7(4):295-298 GOLLOP TR; EIGIER A PRENATAL-DIAGNOSIS OF THALIDOMIDE SYNDROME | 5 | 6 |
| 902 | 2 | 6 | 969 1988 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 56(4):625-625 SALAFIA A; KHARKAR RD THALIDOMIDE AND EXFOLIATIVE DERMATITIS | 6 | 6 |
| 903 | 26 | 64 | 999 1989 MEDICAL HYPOTHESES 30(2):105-109 GUNZLER V THALIDOMIDE - A THERAPY FOR THE IMMUNOLOGICAL CONSEQUENCES OF HIV INFECTION | 4 | 6 |
| 904 | 15 | 23 | 1042 1991 CANCER LETTERS 60(2):129-133 GERSHBEIN LL THE THALIDOMIDE ANALOG, EM-12, ENHANCES 1,2-DIMETHYLHYDRAZINE-INDUCTION OF RAT COLON ADENOCARCINOMAS | 2 | 6 |
| 905 | 8 | 10 | 1054 1992 ARCHIVES OF INTERNAL MEDICINE 152(5):1089-1090 BOUZA E; MUNOZ P; DIAZ MD; VICENTE T THALIDOMIDE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 3 | 6 |
| 906 | 5 | 5 | 1073 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 CRAWFORD CL THALIDOMIDE NEUROPATHY | 5 | 6 |
| 907 | 7 | 10 | 1086 1993 ARCHIVES OF INTERNAL MEDICINE 153(4):534-534 VICENTE T; ORTEGA A; MUNOZ P; DIAZ MD; BOUZA E INVITRO ACTIVITY OF THALIDOMIDE AGAINST MYCOBACTERIUM-AVIUM COMPLEX | 5 | 6 |
| 908 | 7 | 34 | 1113 1993 SPECTROSCOPY LETTERS 26(4):597-619 ROTHCHILD R; SANDERS K; VENKATASUBBAN KS NMR-STUDIES OF DRUGS - USE OF LANTHANIDE SHIFT-REAGENTS IN POLAR-SOLVENT WITH THALIDOMIDE | 0 | 6 |
| 909 | 3 | 5 | 1133 1994 BRITISH MEDICAL JOURNAL 309(6966):1442-1442 TENCONI R; CLEMENTI M; NOTARI L; VASCO VRLO AMNIOTIC BAND SEQUENCE IN CHILD OF THALIDOMIDE VICTIM | 4 | 6 |
| 910 | 22 | 45 | 1162 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):535-542 ARALACHAVES M; VILANOVA M; RIBEIRO A; PINTO J IMMUNOSTIMULATORY EFFECT OF THALIDOMIDE IN NORMAL C57BL/6 MICE IS COMPATIBLE WITH STIMULATION OF A HIGHLY CONNECTED CENTRAL IMMUNE-SYSTEM .1. | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 911 | 10 | 14 | 1197 1995 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 233(2):90-93 GUEXCROSIER Y; PITTET N; HERBORT CP THE EFFECT OF THALIDOMIDE AND SUPIDIMIDE ON ENDOTOXIN-INDUCED UVEITIS IN RATS | 5 | 6 |
| 912 | 5 | 25 | 1291 1996 NEUROREPORT 7(12):1881-1886 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy | 1 | 6 |
| 913 | 0 | 0 | 1294 1996 REPRODUCTIVE TOXICOLOGY 10(1):1-2 Robert E Thalidomide and isotretinoin - Why treat them differently? | 2 | 6 |
| 914 | 3 | 44 | 1309 1997 AMERICAN JOURNAL OF MEDICAL GENETICS 73(3):251-258 Yang QH; Khoury MJ; James LM; Olney RS; Paulozzi LJ; Erickson JD The return of thalidomide: Are birth defects surveillance systems ready? | 1 | 6 |
| 915 | 5 | 5 | 1326 1997 CLINICAL CHEMISTRY 43(6):1094-1095 Eriksson T; Bjorkman S Handling of blood samples for determination of thalidomide | 6 | 6 |
| 916 | 1 | 236 | 1332 1997 COLUMBIA LAW REVIEW 97(7):2153-2176 Bernstein A Formed by thalidomide: Mass torts as a false cure for toxic exposure | 1 | 6 |
| 917 | 5 | 15 | 1407 1998 BIOLOGICAL & PHARMACEUTICAL BULLETIN 21(6):638-640 Ishikawa M; Kanno S; Takayanagi M; Takayanagi Y; Sasaki K Thalidomide promotes the release of tumor necrosis factor-alpha (TNF-alpha) and lethality by lipopolysaccharide in mice | 5 | 6 |
| 918 | 0 | 0 | 1494 1999 ARTHRITIS AND RHEUMATISM 42(9):S373-S373 El Hassani S; Dougados M; Gombert B; Amor B; Breban M Treatment of severe retractory spondylarthopathy (SPA) with thalidomide: Results of an open study. | 2 | 6 |
| 919 | 18 | 29 | 1554 1999 INTERNATIONAL JOURNAL OF TOXICOLOGY 18(5):337-352 Teo SK; Trigg NJ; Shaw ME; Morgan JM; Thomas SD Subchronic toxicity of thalidomide in rodents after 13 weeks of oral administration | 6 | 6 |
| 920 | 15 | 35 | 1600 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):305-311 Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D Treatment of porphyria cutanea tarda with oral thalidomide | 5 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 921 | 15 | 33 | 1631 2000 BIOPHARMACEUTICS & DRUG DISPOSITION 21(1):33-40 Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women | 6 | 6 |
| 922 | 0 | 0 | 1633 2000 BLOOD 96(11):146A-146A Raza A; Lisak L; Little L; Ekbal M; du Rant M; Ali E; Nascimben F; Tareen M; Venugopal P Thalidomide as a single agent or in combination with topotecan, pentoxifylline and/or Enbrel in myelodysplastic syndromes (MDS). | 0 | 6 |
| 923 | 0 | 0 | 1654 2000 BLOOD 96(11):292B-292B Palumbo A; Giaccone L; Bertola A; Bringhen S; Rus C; Triolo S; Pileri A; Boccadoro M Thalidomide and dexamethasone as salvage therapy for refractory and relapsed myeloma. | 0 | 6 |
| 924 | 13 | 49 | 1694 2000 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 121(3):472-479 Guckian M; Dransfield I; Hay P; Dalgleish AG Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro | 4 | 6 |
| 925 | 0 | 0 | 1716 2000 GASTROENTEROLOGY 118(4):A582-A582 Kam LY; Vasiliauskas EA; Abreu MT; Hassard PV; Zeldis J; Targan SR Open labeled pilot study of thalidomide(thal) as a novel therapy for medically resistant ulcerative colitis (UC). | 1 | 6 |
| 926 | 3 | 13 | 1757 2000 LIFE SCIENCES 67(4):457-461 Thiele A; Thormann M; Hofmann HJ; Naumann WW; Eger K; Hauschildt S A possible role of N-cadherin in thalidomide teratogenicity | 4 | 6 |
| 927 | 3 | 15 | 1786 2000 SEMINARS IN HEMATOLOGY 37(1):15-21 Munshi NC; Desikan KR; Barlogie B Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies | 5 | 6 |
| 928 | 8 | 25 | 1796 2000 TETRAHEDRON LETTERS 41(37):7151-7155 Luzzio FA; Thomas EM; Figg WD Thalidomide metabolites and analogs. Part 2: Cyclic derivatives of 2-N-phthalimido-2S,3S (3-hydroxy) ornithine | 4 | 6 |
| 929 | 8 | 12 | 1803 2001 AMERICAN JOURNAL OF HEMATOLOGY 66(4):300-302 Fowler R; Imrie K Thalidomide-associated hepatitis: A case report | 5 | 6 |
| 930 | 11 | 12 | 1807 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(5):611-613 Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A Sarcoidosis: thalidomide treatment in ten patients | 5 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 931 | 0 | 0 | 1843 2001 BLOOD 98(11):163A-163A Durie BGM; Stepan DE Low dose thalidomide alone and in combination: Long term follow-up. | 0 | 6 |
| 932 | 12 | 27 | 2026 2002 AMERICAN JOURNAL OF MEDICINE 113(7):603-606 Bennett CL; Schumock GT; Desai AA; Kwaan HC; Raisch DW; Newlin R; Stadler W Thalidomide-associated deep vein thrombosis and pulmonary embolism | 3 | 6 |
| 933 | 20 | 42 | 2044 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):13-19 Sampaio EP; Hernandez MO; Carvalho DS; Sarno EN Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M-leprae-induced TNF alpha production in vitro | 5 | 6 |
| 934 | 56 | 93 | 2047 2002 BIOMEDICINE & PHARMACOTHERAPY 56(3):115-128 Richardson P; Hideshima T; Anderson K Thalidomide in multiple myeloma | 5 | 6 |
| 935 | 32 | 45 | 2048 2002 BIOMEDICINE & PHARMACOTHERAPY 56(4):194-199 Ng SSW; Brown M; Figg WD Thalidomide, an antiangiogenic agent with clinical activity in cancer | 5 | 6 |
| 936 | 4 | 33 | 2050 2002 BIOORGANIC & MEDICINAL CHEMISTRY 10(9):3067-3073 Lima LM; Castro P; Machado AL; Fraga CAM; Lugnier C; de Moraes VLG; Barreiro EJ Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues | 2 | 6 |
| 937 | 26 | 39 | 2125 2002 BLOOD 100(12):4162-4168 Yaccoby S; Johnson CL; Mahaffey SC; Wezeman MJ; Barlogie B; Epstein J Antimyeloma efficacy of thalidomide in the SCID-hu model | 1 | 6 |
| 938 | 23 | 30 | 2236 2002 JOURNAL OF LEUKOCYTE BIOLOGY 72(5):939-945 Mohty M; Stoppa AM; Blaise D; Isnardon D; Gastaut JA; Olive D; Gaugler A Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide | 2 | 6 |
| 939 | 4 | 26 | 2257 2002 LEUKEMIA & LYMPHOMA 43(2):401-406 Dmoszynska A; Bojarska-Junak A; Domanski D; Rolinski J; Hus M; Soroka-Wojtaszko M Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma | 2 | 6 |
| 940 | 7 | 29 | 2259 2002 LEUKEMIA & LYMPHOMA 43(9):1777-1782 Coleman M; Leonard J; Lyons L; Pekle K; Nahum K; Pearse R; Niesvizky R; Michaeli J BLYD (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenstrom's macroglobulinemia | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 941 | 22 | 30 | 2318 2003 ANTI-CANCER DRUGS 14(5):331-335 Dredge K; Dalgleish AG; Marriott JB Thalidomide analogs as emerging anti-cancer drugs | 2 | 6 |
| 942 | 30 | 38 | 2434 2003 CLINICAL CANCER RESEARCH 9(5):1680-1688 Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Muller G; Ching LM Thalidomide metabolites in mice and patients with multiple myeloma | 5 | 6 |
| 943 | 74 | 144 | 2456 2003 EXPERT OPINION ON INVESTIGATIONAL DRUGS 12(7):1211-1225 Fanelli M; Sarmiento R; Gattuso D; Carillio G; Capaccetti B; Vacca A; Roccaro AM; Gasparini G Thalidomide: a new anticancer drug? | 2 | 6 |
| 944 | 0 | 0 | 24 1961 BRITISH MEDICAL JOURNAL 2(525):1084-& HEATHFIELD K G NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 0 | 5 |
| 945 | 0 | 0 | 25 1961 BRITISH MEDICAL JOURNAL 2(526):1151-& POWELLTUCK GA NEUROPATHY AFTER THALIDOMIDE DISTAVAL | 4 | 5 |
| 946 | 0 | 0 | 50 1962 AMERICAN JOURNAL OF DISEASES OF CHILDREN 104(2):111-& TAUSSIG HB THALIDOMIDE-A LESSON IN REMOTE EFFECTS OF DRUGS | 0 | 5 |
| 947 | 4 | 4 | 108 1962 JOURNAL OF PEDIATRICS 61(2):318-& BLATTNER RJ THALIDOMIDE STUDIES IN EXPERIMENTAL ANIMALS | 3 | 5 |
| 948 | 0 | 0 | 147 1962 LANCET 2(7260):836-& OWEN R; SMITH A COR TRILOCULARE AND THALIDOMIDE | 3 | 5 |
| 949 | 1 | 5 | 182 1963 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA 58(3):355-& MIDTVEDT T EFFECT OF THALIDOMIDE ON GROWTH CURVE OF A RIBOFLAVIN DEPENDENT MICROBE | 0 | 5 |
| 950 | 10 | 16 | 210 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 89(19):987-& WEBB JF CANADIAN THALIDOMIDE EXPERIENCE | 0 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 951 | 2 | 4 | 214 1963 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 257(1):273-& SALZGEBER B; SALAUN J TERATOLOGIE EXPERIMENTALE - ACTION TERATOGENE DE LA THALIDOMIDE SUR LEMBRYON DE POULET, A DIFFERENTS STADES DU DEVELOPPEMENT | 2 | 5 |
| 952 | 0 | 0 | 227 1963 LANCET 1(727):501-& KAJII T; SHINOHARA M THALIDOMIDE IN JAPAN | 1 | 5 |
| 953 | 5 | 10 | 251 1963 NEW ENGLAND JOURNAL OF MEDICINE 269(2):92-& TAUSSIG HB EVILS OF CAMOUFLAGE AS ILLUSTRATED BY THALIDOMIDE | 1 | 5 |
| 954 | 0 | 0 | 267 1964 ANATOMICAL RECORD 148(2):313-& MOORE KL; DWORNIK JJ; DALTON RD CONGENITAL DEFECTS PRODUCED IN RAT BY THALIDOMIDE | 2 | 5 |
| 955 | 9 | 25 | 375 1966 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 8(6):761-& GORDON G MECHANISM OF THALIDOMIDE DEFORMITIES CORRELATED WITH PATHOGENIC EFFECTS OF PROLONGED DOSAGE IN ADULTS | 5 | 5 |
| 956 | 0 | 0 | 380 1966 FEDERATION PROCEEDINGS 25(2P1):532-& MORI A; NYHAN WL; ASHIDA H METABOLISM OF THALIDOMIDE IN PREGNANT RATS | 4 | 5 |
| 957 | 4 | 5 | 410 1966 VETERINARY RECORD 78(25):883-& JAFFE WP FAILURE OF THALIDOMIDE TO INFLUENCE HOMOGRAFT IMMUNITY IN CHICKENS | 5 | 5 |
| 958 | 3 | 8 | 452 1968 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 49(2):179-& VICKERS TH CARDIOVASCULAR MALFORMATIONS IN RABBIT THALIDOMIDE EMBRYOPATHY | 2 | 5 |
| 959 | 1 | 1 | 453 1968 BRITISH JOURNAL OF HAEMATOLOGY 15(3):322-& LEWIS HBM; ALBERTRE.F; WALKER W COLD HAEMAGGLUTINATION DISEASE TREATED BY THALIDOMIDE | 0 | 5 |
| 960 | 0 | 0 | 496 1970 ARCHIV FUR KLINISCHE UND EXPERIMENTELLE DERMATOLOGIE 237(1):312-& SHESKIN J; SAGHER F CURRENT STATUS OF THALIDOMIDE TREATMENT OF LEPROSY AND LEPRA REACTIONS | 2 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 961 | 3 | 11 | 502 1970 EXPERIENTIA 26(3):305-& MIURA M; WUEST H POTENTIATING EFFECT OF THALIDOMIDE ON METHYLCHOLANTHRENE ONCOGENESIS IN MICE | 2 | 5 |
| 962 | 1 | 14 | 504 1970 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 171(1):109-& BAKAY B; NYHAN WL EFFECTS OF THALIDOMIDE AND CHLORCYCLIZINE ON BIOSYNTHESIS OF NUCLEIC ACIDS AND PROTEINS IN FETAL AND MATERNAL TISSUES OF RAT | 4 | 5 |
| 963 | 0 | 0 | 533 1971 TERATOLOGY 4(2):247-& TANIMURA T; TANAKA O; NISHIMUR.H EFFECTS OF THALIDOMIDE AND QUINE DIHYDROCHLORIDE ON JAPANESE AND RHESUS MONKEY EMBRYOS | 2 | 5 |
| 964 | 6 | 29 | 569 1973 FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE 41(7):378-417 GIBBELS E; SCHEID W; WIECK HH; KINZEL W THALIDOMIDE-NEUROPATHY IN LATE STAGE | 6 | 5 |
| 965 | 6 | 21 | 574 1973 LANCET 2(7828):567-568 CRAWFORD CL TREATMENT OF ERYTHEMA-NODOSUM LEPROSUM WITH THALIDOMIDE | 5 | 5 |
| 966 | 2 | 13 | 649 1977 JOURNAL OF MEDICAL PRIMATOLOGY 6(5):319-324 BUTLER H EFFECT OF THALIDOMIDE ON A PROSIMIAN - GREATER GALAGO (GALAGO-CRASSICAUDATUS) | 3 | 5 |
| 967 | 0 | 0 | 670 1978 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 46(1):120-120 HASTINGS RC; MORALES MJ EFFECT OF THALIDOMIDE ON NEUTROPHIL FUNCTION | 5 | 5 |
| 968 | 1 | 3 | 674 1978 LANCET 1(8068):826-826 BREMNER DN; MOONEY G AGENESIS OF APPENDIX - FURTHER THALIDOMIDE ANOMALY | 0 | 5 |
| 969 | 2 | 15 | 718 1980 ARCHIV DER PHARMAZIE 313(6):481-487 FICKENTSCHER K; HALFMANN U; KOHLER F SYNTHESIS AND TERATOGENIC ACTIVITY OF SOME THALIDOMIDE ANALOGOUS INDANE-1,3-DIONES | 5 | 5 |
| 970 | 1 | 7 | 748 1981 DERMATOLOGICA 163(2):145-150 SHESKIN J; GORODETSKY R; WEINREB A; LOEWINGER E IRON CONTENT OF SKIN BEFORE AND AFTER THALIDOMIDE TREATMENT OF LEPRA REACTION - A PRELIMINARY-REPORT | 0 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 971 | 2 | 6 | 861 1984 REVUE DU RHUMATISME 51(10):585-585 TREVES R; ARNAUD M; JACOB P; LUBEAU M; TABARAUD F; BURKI F; DESPROGESGOTTERON R DRAMATIC IMPROVEMENT IN THE ARTHRITIS OF BEHCETS-DISEASE FOLLOWING THE ADMINISTRATION OF THALIDOMIDE - A CASE-REPORT | 3 | 5 |
| 972 | 2 | 3 | 876 1985 ARTHRITIS AND RHEUMATISM 28(7):836-836 MIYACHI Y A POSSIBLE MECHANISM OF ACTION OF THALIDOMIDE ON RHEUMATOID-ARTHRITIS | 5 | 5 |
| 973 | 8 | 15 | 916 1986 BRITISH JOURNAL OF DERMATOLOGY 115(6):677-680 MAURICE PDL; BARKLEY ASJ; ALLEN BR THE EFFECT OF THALIDOMIDE ON ARACHIDONIC-ACID METABOLISM IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND PLATELETS | 5 | 5 |
| 974 | 4 | 5 | 967 1988 DERMATOLOGICA 176(2):107-107 VIRABEN R; DUPRE A ERYTHEMA-NODOSUM FOLLOWING THALIDOMIDE THERAPY FOR BEHCET DISEASE | 1 | 5 |
| 975 | 7 | 27 | 1005 1990 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 40-1(1):32-36 BUCH HP; OMLOR G; KNABE J STEREOSELECTIVE DIFFERENCES OF THE CNS-DEPRESSANT ACTIVITY IN A HOMOLOGOUS SERIES OF 3-ALKYL-THALIDOMIDE ANALOGS | 0 | 5 |
| 976 | 11 | 14 | 1011 1990 EUROPEAN SURGICAL RESEARCH 22(6):336-339 EMRE S; SUMRANI N; HONG J BENEFICIAL EFFECT OF THALIDOMIDE AND CICLOSPORIN COMBINATION IN HETEROTOPIC CARDIAC TRANSPLANTATION IN RATS | 5 | 5 |
| 977 | 4 | 10 | 1039 1991 BRITISH MEDICAL JOURNAL 303(6800):470-470 WATERS MFR USE OF THALIDOMIDE IN LEPROSY | 5 | 5 |
| 978 | 8 | 31 | 1058 1992 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 230(2):140-149 STROMLAND K; MILLER MT REFRACTIVE EVALUATION IN THALIDOMIDE EMBRYOPATHY | 3 | 5 |
| 979 | 5 | 6 | 1067 1992 LANCET 339(8805):1362-1362 CARMICHAEL AJ; KNIGHT A THALIDOMIDE - A RESTRICTED ROLE | 3 | 5 |
| 980 | 0 | 0 | 1075 1992 TERATOLOGY 46(5):417-418 LENZ W A PERSONAL PERSPECTIVE ON THE THALIDOMIDE TRAGEDY | 2 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 981 | 9 | 34 | 1142 1994 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 16(4):717-729 SHANNON EJ; HOWE RC; MCLEAN K; HASTINGS RC THALIDOMIDE DOES NOT PERTURB CD2, CD4, CD5, CD8, HLA-DR, OR HLA-A, HLA-B, HLA-C MOLECULES IN-VITRO ON THE MEMBRANES OF CELLS WITH IMMUNE POTENTIAL | 5 | 5 |
| 982 | 0 | 1 | 1149 1994 LANCET 343(8900):795-796 CUTLER J THALIDOMIDE REVISITED | 4 | 5 |
| 983 | 3 | 5 | 1150 1994 LANCET 343(8904):1041-1041 JONES GRN THALIDOMIDE - 35 YEARS ON AND STILL DEFORMING | 4 | 5 |
| 984 | 11 | 26 | 1163 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):543-548 VILANOVA M; RIBEIRO A; CARNEIRO J; ARALACHAVES M THE EFFECTS OF THALIDOMIDE TREATMENT ON AUTOIMMUNE-PRONE NZB AND MRL MICE ARE CONSISTENT WITH STIMULATION OF THE CENTRAL IMMUNE-SYSTEM .2. | 4 | 5 |
| 985 | 10 | 14 | 1204 1995 JOURNAL OF LIQUID CHROMATOGRAPHY 18(2):297-309 DELON A; FAVRELIERE S; COUET W; COURTOIS PH; BOUQUET S RAPID AND SENSITIVE DETERMINATION OF THALIDOMIDE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY | 5 | 5 |
| 986 | 0 | 0 | 1217 1995 NATURE MEDICINE 1(12):1230-1230 GERSHON D FINDING NEW USES FOR THALIDOMIDE | 3 | 5 |
| 987 | 9 | 12 | 1230 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):368-& Weidle PJ Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus | 5 | 5 |
| 988 | 24 | 33 | 1285 1996 LUPUS 5(4):257-258 Stevens RJ The place of thalidomide in the treatment of inflammatory disease | 3 | 5 |
| 989 | 9 | 51 | 1297 1996 TERATOLOGY 54(3):126-134 Smith DM; Torres RD; Stephens TD Mesonephros has a role in limb development and is related to thalidomide embryopathy | 0 | 5 |
| 990 | 6 | 35 | 1341 1997 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 19(3):313-326 Aseffa A; Dietrich MA; Shannon EJ Effect of thalidomide on apoptosis of lymphocytes and neutrophils | 4 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 991 | 7 | 11 | 1389 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):R1-R2 Neubert D Never-ending tales of the mode of the teratogenic action of thalidomide | 3 | 5 |
| 992 | 6 | 10 | 1427 1998 CLINICAL AND EXPERIMENTAL DERMATOLOGY 23(5):233-235 Herranz P; Pizarro A; de Lucas R; Arribas JR; Garcia-Tobaruela A; Pena JM; Casado M Treatment of AIDS-associated prurigo nodularis with thalidomide | 4 | 5 |
| 993 | 12 | 15 | 1449 1998 JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES 21(14):2151-2163 Haque A; Stewart JT Determination of racemic thalidomide in human plasma by use of an avidin column and solid phase extraction | 3 | 5 |
| 994 | 2 | 19 | 1465 1998 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 20(9):739-742 Guinan P; Shaw M; Mirochnik Y; Slobodskoy L; Ray V; Rubenstein M Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model | 2 | 5 |
| 995 | 0 | 0 | 1492 1999 ARTHRITIS AND RHEUMATISM 42(9):S187-S187 Oliver SJ; Moreira A; Kaplan G Reduced fibrosis and normalization of skin structure in scleroderma patients treated with thalidomide. | 1 | 5 |
| 996 | 0 | 0 | 1515 1999 BLOOD 94(10):507A-507A Thomas DA; Aguayo A; Estey E; Albitar M; O'Brien S; Giles FJ; Beran M; Cortes J; Zeldis J; Keating MJ; Barlogie B; Kantarjian HM Thalidomide as anti-angiogenesis therapy (RX) in refractory or relapsed leukemias. | 0 | 5 |
| 997 | 11 | 51 | 1524 1999 CELLULAR AND MOLECULAR BIOLOGY 45(5):579-588 Gaffield W; Incardona JP; Kapur RP; Roelink H A looking glass perspective: Thalidomide and cyclopamine | 0 | 5 |
| 998 | 4 | 10 | 1528 1999 CLINICAL INFECTIOUS DISEASES 28(4):892-894 Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial | 4 | 5 |
| 999 | 6 | 11 | 1529 1999 CLINICAL NEUROPHYSIOLOGY 110(4):735-739 Sadoh DR; Hawk JLM; Panayiotopoulos CP F-chronodispersion in patients on thalidomide | 5 | 5 |
| 1000 | 2 | 5 | 1534 1999 DERMATOLOGY 199(2):195-195 Bez C; Lodi G; Sardella A; Della Volpe A; Carrassi A Oral lichenoid lesions after thalidomide treatment | 5 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1001 | 0 | 0 | 1539 1999 GASTROENTEROLOGY 116(4):A745-A745 Kane SV; Ehrenpreis ED; Cohen LB; Hanauer SB; Cohen RD Therapeutic efficacy of thalidomide for patients with refractory Crohn's disease (CD) | 2 | 5 |
| 1002 | 3 | 10 | 1578 1999 LUPUS 8(3):248-249 Rua-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernandez G; Rodriguez-Lozano C; De la Rosa P Pustuloderma during cutaneous lupus treatment with thalidomide | 3 | 5 |
| 1003 | 0 | 0 | 1628 2000 ARTHRITIS AND RHEUMATISM 43(9):S396-S396 Huang F; Gu J; Braun J; Sieper J; Yu DT Identifying the targets of thalidomide and anti-TNF alpha antibody treatments in ankylosing spondylitis (AS). | 2 | 5 |
| 1004 | 0 | 0 | 1652 2000 BLOOD 96(11):290B-290B Moehler TM; Neben K; Hawighorst H; Egerer G; van Kaick G; Ho AD; Goldschmidt H Thalidomide plus CED chemotherapy as salvage therapy in poor prognosis multiple myeloma. | 0 | 5 |
| 1005 | 0 | 0 | 1665 2000 BLOOD 96(11):364A-364A Rajkumar SV; Timm M; Mesa RA; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Gertz MA; Kyle RA; Griepp PR; Witzig TE Effect of thalidomide on myeloma cell apoptosis and VEGF secretion. | 0 | 5 |
| 1006 | 1 | 1 | 1686 2000 BRITISH JOURNAL OF HAEMATOLOGY 111(3):986-986 Myers B; Crouch D; Dolan G Thalidomide treatment in advanced refractory myeloma | 5 | 5 |
| 1007 | 3 | 20 | 1725 2000 INFLAMMATION 24(4):347-356 Lindsay L; Oliver SJ; Freeman SL; Josien R; Krauss A; Kaplan G Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone | 1 | 5 |
| 1008 | 9 | 15 | 1745 2000 JOURNAL OF INFECTIOUS DISEASES 181(5):1813-1816 Juffermans NP; Verbon A; Olszyna DP; van Deventer SJH; Speelman P; van der Poll T Thalidomide suppresses up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4(+) T cells in humans | 3 | 5 |
| 1009 | 4 | 5 | 1763 2000 MUSCLE & NERVE 23(8):1301-1302 Rao DG; Kane NM; Oware A Thalidomide neuropathy: Role of F-wave monitoring | 5 | 5 |
| 1010 | 1 | 1 | 1767 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(13):975-975 Kishi Y; Oki Y; Machida U Thalidomide in multiple myeloma | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1011 | 5 | 42 | 1789 2000 SEMINARS IN HEMATOLOGY 37(1):35-39 Alexanian R; Anderson KC; Barlogie B; Stirling DI; Thomas DA Thalidomide in hematologic malignancies: Future directions | 5 | 5 |
| 1012 | 22 | 30 | 1809 2001 ANNALS OF ONCOLOGY 12(7):885-886 Thomas DA; Kantarjian HM The revitalization of thalidomide | 4 | 5 |
| 1013 | 6 | 6 | 1819 2001 ARTHRITIS AND RHEUMATISM 44(10):2456-2457 Lee L; Lawford R; McNeil HP The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al | 2 | 5 |
| 1014 | 1 | 4 | 1820 2001 ARTHRITIS AND RHEUMATISM 44(10):2457-2458 Breban M; Dougados M The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: Reply | 2 | 5 |
| 1015 | 0 | 0 | 1837 2001 BLOOD 98(11):162A-162A Wechalekar AD; Sutton D; Voralia M; Stewart AK; Chen CI Intermediate dose thalidomide (200mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma. | 0 | 5 |
| 1016 | 0 | 0 | 1842 2001 BLOOD 98(11):163A-163A Grosbois B; Bellissant E; Moreau P; Attal M; Zerbib R Thalidomide (Thal) in the treatment of advanced multiple myeloma (MM). A prospective study of 120 patients. | 0 | 5 |
| 1017 | 0 | 0 | 1875 2001 BLOOD 98(11):849A-849A Rajkumar SV; Hayman SR; Gertz MA; Dispenzieri A; Lacy M; Greipp PR; Geyer S; Itturia N; Fonseca R; Lust JA; Kyle R; Witzig TE Combination therapy with thalidomide plus dexamethasone (THAL/DEX) for newly diagnosed myeloma (MM). | 0 | 5 |
| 1018 | 10 | 38 | 1881 2001 BONE MARROW TRANSPLANTATION 28(12):1145-1150 Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation | 3 | 5 |
| 1019 | 11 | 31 | 1898 2001 CANCER CHEMOTHERAPY AND PHARMACOLOGY 47(6):541-544 Zhou SF; Kestell P; Tingle MD; Ching LM; Paxton JW A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide | 2 | 5 |
| 1020 | 3 | 10 | 1902 2001 CHILDS NERVOUS SYSTEM 17(6):370-372 Schoeman JF; Ravenscroft A; Hartzenberg HB Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess | 5 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1021 | 3 | 3 | 1905 2001 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 19(3):360-361 Scoville CD Pilot study using the combination of methotrexate and thalidomide in the treatment of rheumatoid arthritis | 5 | 5 |
| 1022 | 5 | 20 | 1942 2001 HAUTARZT 52:962-965 Hoch O; Muller S; Buttner G; Mensing H Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 3 | 5 |
| 1023 | 0 | 0 | 1951 2001 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 42(4):S233-S233 Maguire MG; Fine SL; Maguire AM; D'Amato RJ; Singerman LJ Results of the age-related macular degeneration and thalidomide study (AMDATS). | 0 | 5 |
| 1024 | 6 | 6 | 1972 2001 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 45(6):965-966 George SJ; Hsu S Lichen planopilaris treated with thalidomide | 2 | 5 |
| 1025 | 0 | 5 | 1973 2001 LANCET ONCOLOGY 2(10):634-635 Hwu WJ; Raizer J; Panageas KS; Lis E Treatment of metastatic melanoma in the brain with temozolomide and thalidomide | 3 | 5 |
| 1026 | 3 | 3 | 1998 2001 PRESSE MEDICALE 30(20):1008-1009 Pouaha J; Martin S; Trechot P; Truchetet F; Barbaud A; Schmutz JL Thalidomide and thrombosis: three cases | 5 | 5 |
| 1027 | 9 | 36 | 2035 2002 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 46(6):1887-1895 Tsenova L; Mangaliso B; Muller G; Chen Y; Freedman VH; Stirling D; Kaplan G Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis | 3 | 5 |
| 1028 | 0 | 0 | 2067 2002 BLOOD 100(11):105A-105A Zangari M; Barlogie B; Prather J; Eddlemon P; Anaissie E; Lee CK; Tricot G; Thertulien R; van Rhee F Marked activity also in del 13 multiple myeloma (MM) of PS 341 (PS) and subsequent thalidomide (THAL) in a setting of resistance to post-autotransplant salvage therapies. | 0 | 5 |
| 1029 | 110 | 164 | 2176 2002 DRUGS & AGING 19(2):85-100 Zhou SF; Kestell P; Tingle MD; Paxton JW Thalidomide in cancer treatment - A potential role in the elderly? | 4 | 5 |
| 1030 | 10 | 15 | 2217 2002 JOURNAL OF CLINICAL GASTROENTEROLOGY 35(2):149-150 Kane S; Stone LJ; Ehrenpreis E Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab - A case series | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1031 | 13 | 15 | 2232 2002 JOURNAL OF INFECTIOUS DISEASES 185(9):1359-1363 Wohl DA; Aweeka FT; Schmitz J; Pomerantz R; Cherng DW; Spritzler J; Fox L; Simpson D; Bell D; Holohan MK; Thomas S; Robinson W; Kaplan G; Teppler H; Natl Inst Allergy Infect Dis AIDS Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267 | 5 | 5 |
| 1032 | 15 | 40 | 2243 2002 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 300(3):768-776 Hansen JM; Harris KK; Philbert MA; Harris C Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb | 2 | 5 |
| 1033 | 18 | 38 | 2262 2002 LUPUS 11(2):67-70 Piette JC; Sbai A; Frances C Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus | 3 | 5 |
| 1034 | 7 | 17 | 2266 2002 MEDICAL ONCOLOGY 19(2):79-86 Merup M; Kutti J; Birgergard G; Mauritzson N; Bjorkholm M; Markevarn B; Malm C; Westin J; Palmblad J; Samuelsson J; Swedish Natl Study Grp Chronic Mye Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia | 4 | 5 |
| 1035 | 4 | 17 | 2275 2002 ONCOLOGY-NEW YORK 16(4):23-26 Govindarajan R Irinoteean/Thalidomide in metastatic colorectal cancer | 4 | 5 |
| 1036 | 5 | 12 | 2413 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(1):101-103 Steurer M; Sudmeier I; Stauder R; Gastl G Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha | 3 | 5 |
| 1037 | 5 | 34 | 2425 2003 CANCER 97(5):1234-1241 Cortes J; Kantarjian H; Albitar M; Thomas D; Faderl S; Koller C; Garcia-Manero G; Giles F; Andreeff M; O'Brien S; Keating M; Estey E A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome | 1 | 5 |
| 1038 | 21 | 31 | 2429 2003 CANCER RESEARCH 63(12):3189-3194 Ng SSW; Gutschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues | 3 | 5 |
| 1039 | 166 | 221 | 2442 2003 CLINICAL THERAPEUTICS 25(2):342-395 Matthews SJ; McCoy C Thalidomide: A review of approved and investigational uses | 2 | 5 |
| 1040 | 7 | 29 | 2560 2003 SEMINARS IN ONCOLOGY 30(2):270-274 Coleman M; Leonard J; Lyons L; Szelenyi H; Niesvizky R Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1041 | 0 | 0 | 8 1960 FEDERATION PROCEEDINGS 19(1):264-264 KUHN WL; VANMAANEN EF EFFECTS OF THALIDOMIDE ON CENTRAL NERVOUS SYSTEM DRUGS | 2 | 4 |
| 1042 | 0 | 3 | 10 1960 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 103(3):580-581 HARRIS SC; ALLGOOD JP ANALGESIA ENHANCING EFFECT OF THALIDOMIDE | 1 | 4 |
| 1043 | 0 | 0 | 26 1961 BRITISH MEDICAL JOURNAL 2(526):1223-& STEVENSON JS NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 0 | 4 |
| 1044 | 0 | 0 | 28 1961 BRITISH MEDICAL JOURNAL 2(526):1223-& CAHILL PK NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 4 |
| 1045 | 0 | 0 | 48 1961 MEDICAL JOURNAL OF AUSTRALIA 2(26):1030-& MCBRIDE WG CONGENITAL ABNORMALITIES AND THALIDOMIDE | 3 | 4 |
| 1046 | 7 | 25 | 174 1962 PRESSE MEDICALE 70(44):2053-& FARIZON F; MASBERNARD A EMBRYOPATHIE A LA THALIDOMIDE | 3 | 4 |
| 1047 | 7 | 9 | 204 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):959-& MARTIN JK; RATHBUN JC HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - PEDIATRIC ASPECTS | 4 | 4 |
| 1048 | 0 | 0 | 218 1963 FEDERATION PROCEEDINGS 22(2):666-& DIPAOLO JA THALIDOMIDE - INFLUENCE ON PRODUCTION OF CONGENITAL ABNORMALITIES IN MICE AND CANCER CHEMOTHERAPY | 3 | 4 |
| 1049 | 0 | 4 | 225 1963 LANCET 1(727):174-& PETERSEN CE; WIEDEMANN HR THALIDOMIDE AND FOETAL ABNORMALITIES | 2 | 4 |
| 1050 | 3 | 8 | 266 1964 ANALYTICAL BIOCHEMISTRY 8(1):129-& SANDBERG DH; TURNER DA; BOCK SA QUANTITATIVE MEASUREMENT OF THALIDOMIDE BY GAS-LIQUID CHROMATOGRAPHY | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1051 | 14 | 21 | 273 1964 BIOCHEMICAL PHARMACOLOGY 13(6):940-& CHAUDHARY KD; LEMONDE A EFFECT OF THALIDOMIDE ON TRIBOLIUM CONFUSUM DUVAL | 2 | 4 |
| 1052 | 19 | 58 | 274 1964 BIOCHEMICAL PHARMACOLOGY 13(11):1489-& TOIVANEN A; TOIVANEN P; MANTYJAR.R; MARKKANEN T MICROBIOLOGICALLY DETERMINED PANTOTHENIC ACID + NICOTINIC ACID CONTENT OF CHICK EMBRYOS AFTER TREATMENT WITH THALIDOMIDE + OF RAT FETUSES NEWBORNS + PLACENTAS FROM MOTHERS TREATED WITH THALIDOMIDE | 2 | 4 |
| 1053 | 7 | 10 | 299 1964 POULTRY SCIENCE 43(6):1420-& KONDRA PA; SELL JL; MCKIRDY JA EFFECT OF THALIDOMIDE ON REPRODUCTION IN HEN | 2 | 4 |
| 1054 | 1 | 8 | 324 1965 CANADIAN MEDICAL ASSOCIATION JOURNAL 92(6):283-& HAGEN EO CONGENITAL MALFORMATIONS IN A THALIDOMIDE BABY - A POSTMORTEM ANATOMICAL STUDY | 3 | 4 |
| 1055 | 0 | 3 | 332 1965 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 260(15):4208-& CHAMPYHA.S IMIDAZOLE ET THALIDOMIDE . ETUDE SPECTRALE COMPAREE DES DEUX NOYAUX PHTALIMIDE ET GLUTARIMIDE | 0 | 4 |
| 1056 | 3 | 12 | 338 1965 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 13:235-& MARINPAD.M; BENIRSCH.K THALIDOMIDE INJURY TO MYOCARDIUM OF ARMADILLO EMBRYOS | 0 | 4 |
| 1057 | 0 | 3 | 396 1966 LANCET 1(7447):1134-& CANT JS MINOR OCULAR ABNORMALITIES ASSOCIATED WITH THALIDOMIDE | 2 | 4 |
| 1058 | 1 | 33 | 419 1967 ARZNEIMITTEL-FORSCHUNG 17(9):1155-& CHAMPYHA.S CONJUGATED ACTION OF 2 NUCLEI OF THALIDOMIDE ON IMIDAZOLINE COMPOUNDS - HISTAMINE AND PURINE BASES | 0 | 4 |
| 1059 | 6 | 15 | 426 1967 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 48(2):150-& COOK MJ; MOORE DF EFFECT OF THALIDOMIDE ON DEVELOPING RAT FOETUS | 1 | 4 |
| 1060 | 0 | 0 | 460 1968 FEDERATION PROCEEDINGS 27(2):494-& OGILVIE JW; KANTOR FS EFFECT OF THALIDOMIDE ON IMMUNE RESPONSE | 4 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1061 | 1 | 8 | 482 1969 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 11(6):743-& SIMARD TG; LADD HW CONSCIOUS CONTROL OF MOTOR UNITS WITH THALIDOMIDE CHILDREN - AN ELECTROMYOGRAPHIC STUDY | 0 | 4 |
| 1062 | 9 | 54 | 514 1971 ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 194(1):39-& LOCKER D; SUPERSTI.E; SULMAN FG MECHANISM OF PUSH AND PULL PRINCIPLE .8. ENDOCRINE EFFECTS OF THALIDOMIDE AND ITS ANALOGUES | 4 | 4 |
| 1063 | 3 | 11 | 515 1971 ARZNEIMITTEL-FORSCHUNG 21(12):2022-& KOCH H; STOCKING.L TERATOLOGY STUDY ON 3-(1,4-ENDOXO-CYCLOHEXANE-2-EXO-3-EXO-DICARBOXIMIDO)-PIPERIDINE-2,6-DIONE (K-2604), ANOTHER COMPOUND WITH SEDATIVE-HYPNOTIC ACTIVITY AND STRUCTURALLY RELATED TO THALIDOMIDE | 2 | 4 |
| 1064 | 0 | 2 | 529 1971 NEW ENGLAND JOURNAL OF MEDICINE 284(9):481-& CURRAN WJ THALIDOMIDE TRAGEDY IN GERMANY - END OF A HISTORIC MEDICOLEGAL TRIAL | 1 | 4 |
| 1065 | 6 | 10 | 557 1972 PHARMAZIE 27(6):418-& MEISE W SYNTHESIS AND TERATOLOGICAL TESTING OF SOME THALIDOMIDE METABOLITES | 2 | 4 |
| 1066 | 0 | 0 | 561 1972 TERATOLOGY 5(2):257-& HENDRICK.AG; NEWMAN L TEMPORAL AND MANDIBULAR BONE MALFORMATIONS INDUCED BY THALIDOMIDE IN BONNET MONKEY (M RADIATA) | 0 | 4 |
| 1067 | 0 | 23 | 572 1973 KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE 162(4):546-550 TRIESCHM.W CROCODILE TEARS IN THALIDOMIDE EMBRYOPATHY | 0 | 4 |
| 1068 | 6 | 23 | 588 1973 TOXICOLOGY AND APPLIED PHARMACOLOGY 25(1):77-83 GILANI SH CARDIOVASCULAR MALFORMATIONS IN CHICK-EMBRYO INDUCED BY THALIDOMIDE | 1 | 4 |
| 1069 | 0 | 0 | 626 1976 LANCET 2(7989):794-794 HOFFMANN W; GROSPIETSCH G; KUHN W THALIDOMIDE AND FEMALE GENITAL MALFORMATIONS | 0 | 4 |
| 1070 | 1 | 2 | 675 1978 LANCET 1(8072):1042-1042 SMITHELLS RW THALIDOMIDE, ABSENT APPENDIX, AND SWEATING | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1071 | 2 | 13 | 750 1981 EUROPEAN JOURNAL OF PEDIATRICS 136(3):229-230 BURGIO GR THE THALIDOMIDE DISASTER BRIEFLY REVISITED | 3 | 4 |
| 1072 | 4 | 10 | 785 1982 NATURWISSENSCHAFTEN 69(4):191-192 KOCHERBECKER U; KOCHER W; OCKENFELS H TERATOGENIC ACTIVITY OF A HYDROLYTIC THALIDOMIDE METABOLITE IN MICE | 3 | 4 |
| 1073 | 0 | 0 | 790 1982 TERATOLOGY 25(2):A47-A47 HELM FC; FRANKUS E CHEMICAL-STRUCTURE AND TERATOGENIC ACTIVITY OF THALIDOMIDE-RELATED COMPOUNDS | 4 | 4 |
| 1074 | 7 | 12 | 824 1983 HAUTARZT 34(9):435-436 KNOP J; MACHER E THALIDOMIDE IN THE TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 4 | 4 |
| 1075 | 2 | 37 | 829 1983 PERSPECTIVES IN BIOLOGY AND MEDICINE 27(1):93-106 WYATT HV DID THALIDOMIDE PROMOTE POLIOMYELITIS FOLLOWING ORAL POLIOVIRUS VACCINATION IN WEST-BERLIN IN 1960 | 0 | 4 |
| 1076 | 2 | 4 | 831 1983 PRESSE MEDICALE 12(47):3007-3007 PRIGENT F; OUAZZANI W SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 4 | 4 |
| 1077 | 3 | 20 | 891 1985 JOURNAL OF CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY 5(2):147-157 NEWMAN LM; HENDRICKX AG TEMPOROMANDIBULAR MALFORMATIONS IN THE BONNET MONKEY (MACACA-RADIATA) FETUS FOLLOWING MATERNAL INGESTION OF THALIDOMIDE | 0 | 4 |
| 1078 | 2 | 10 | 955 1988 ARCHIV DER PHARMAZIE 321(6):371-373 KOCH HP; STEINACKER C IMPROVEMENT OF SOLUBILITY AND STABILITY OF THALIDOMIDE BY INCLUSION COMPLEXATION WITH CYCLODEXTRINS | 2 | 4 |
| 1079 | 5 | 5 | 962 1988 ARTHRITIS AND RHEUMATISM 31(1):145-146 GUTIERREZRODRIGUEZ O; STARUSTABACAL P; GUTIERREZMONTES O THALIDOMIDE-INDUCED NEUROPATHY IN RHEUMATOID-ARTHRITIS PATIENTS | 2 | 4 |
| 1080 | 5 | 8 | 965 1988 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 95(7):717-719 MAOURIS PG; HIRSCH PJ PREGNANCY IN WOMEN WITH THALIDOMIDE-INDUCED DISABILITIES - CASE-REPORT AND A QUESTIONNAIRE STUDY | 0 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1081 | 0 | 0 | 979 1988 TERATOLOGY 38(3):201-202 FRASER FC THALIDOMIDE RETROSPECTIVE - WHAT DID WE LEARN | 1 | 4 |
| 1082 | 3 | 17 | 987 1989 ARCHIV DER PHARMAZIE 322(8):499-505 KNABE J; OMLOR G SYNTHESES OF THE RACEMATES AND THE ENANTIOMERS OF ANALOGS OF THALIDOMIDE ALKYLATED IN 3-POSITION AND DETERMINATION OF THEIR ABSOLUTE-CONFIGURATION | 2 | 4 |
| 1083 | 0 | 0 | 1026 1990 MEDICINA CLINICA 94(16):638-639 BERNARDO P; ARRIZABALAGA J; IRIBARREN JA; GARDE C EFFECTIVENESS OF THALIDOMIDE IN NONSPECIFIC ESOPHAGEAL ULCERS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY SYNDROME | 3 | 4 |
| 1084 | 7 | 19 | 1032 1990 TERATOLOGY 41(2):243-244 KOCH HP PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 2 | 4 |
| 1085 | 0 | 0 | 1078 1992 TROPICAL DOCTOR 22(3):139-139 AWOFESO N THALIDOMIDE PERIPHERAL NEUROPATHY | 1 | 4 |
| 1086 | 0 | 0 | 1079 1992 TROPICAL DOCTOR 22(3):139-140 WATERS MFR THALIDOMIDE PERIPHERAL NEUROPATHY - REPLY | 2 | 4 |
| 1087 | 0 | 0 | 1126 1994 BRITISH MEDICAL JOURNAL 308(6936):1061-1061 ROCHA J THALIDOMIDE GIVEN TO WOMEN IN BRAZIL | 3 | 4 |
| 1088 | 5 | 5 | 1127 1994 BRITISH MEDICAL JOURNAL 308(6941):1437-1438 CRAWFORD CL SAFETY OF THALIDOMIDE | 4 | 4 |
| 1089 | 11 | 20 | 1147 1994 JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 (9):2063-2067 REEPMEYER JC; RHODES MO; COX DC; SILVERTON JV CHARACTERIZATION AND CRYSTAL-STRUCTURE OF 2 POLYMORPHIC FORMS OF RACEMIC THALIDOMIDE | 3 | 4 |
| 1090 | 3 | 5 | 1151 1994 LANCET 344(8916):196-197 TEIXEIRA F; HOJYO MT; ARENAS R; VEGA ME; CORTES R; ORTIZ A; DOMINGUEZ L THALIDOMIDE - CAN IT CONTINUE TO BE USED | 4 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1091 | 7 | 45 | 1153 1994 LIFE SCIENCES 56(6):407-420 NEUBERT R; HELGE H; NEUBERT D THALIDOMIDE AND THE IMMUNE-SYSTEM .4. DOWN-REGULATION OF THE CD26 RECEPTOR, PROBABLY INVOLVED IN THE BINDING OF HIV COMPONENTS TO T-CELLS IN PRIMATES | 3 | 4 |
| 1092 | 11 | 16 | 1231 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):429-431 Minor JR; Piscitelli SC Thalidomide in diseases associated with human immunodeficiency virus infection | 3 | 4 |
| 1093 | 19 | 42 | 1329 1997 CLINICAL NEUROPHARMACOLOGY 20(2):152-164 Zhu J; Bai XF; Mix E; vanderMeide PH; Zwingenberger K; Link H Thalidomide suppresses T-and B-cell responses to myelin antigen in experimental allergic neuritis | 3 | 4 |
| 1094 | 19 | 23 | 1356 1997 JOURNAL OF AOAC INTERNATIONAL 80(4):767-773 Reepmeyer JC; Cox DC Liquid chromatographic determination of thalidomide in tablets, capsules, and raw materials | 0 | 4 |
| 1095 | 2 | 5 | 1373 1997 NATURE 389(6647):118-118 Ashby J Thalidomide is not a mutagen | 3 | 4 |
| 1096 | 0 | 2 | 1385 1997 SCIENTIST 11(3):1-& Brown KS New uses for thalidomide yielding valuable lessons | 1 | 4 |
| 1097 | 0 | 0 | 1415 1998 BLOOD 92(10):344B-344B Kulkarni S; Powles R; Mehta J; Horton C; Treleaven J; Meller S; Atra A; Pinkerton CR; Singhal S Thalidomide in GVHD - S anti-GVHD effect separable from the antiangiogenesis? | 0 | 4 |
| 1098 | 9 | 10 | 1431 1998 DRUG SAFETY 19(5):339-341 Smithells D Does thalidomide cause second generation birth defects? | 4 | 4 |
| 1099 | 3 | 5 | 1476 1998 REVUE DE MEDECINE INTERNE 19(3):208-209 Grasland A; Pouchot J; Chaumaiziere D; Aitken G; Vinceneux P Effectiveness of thalidomide in cutaneous sarcoidosis | 3 | 4 |
| 1100 | 2 | 29 | 1551 1999 INFLAMMATION 23(6):495-505 Gallily R; Kipper-Galperin M; Brenner T Mycoplasma fermentans-induced inflammatory response of astrocytes: Selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10 | 1 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1101 | 4 | 11 | 1582 1999 NATURE 400(6743):419-420 Neubert R; Merker HT; Neubert D Developmental model for thalidomide action | 3 | 4 |
| 1102 | 0 | 0 | 1593 1999 PEDIATRIC RESEARCH 45(4):67A-67A Jakkula M; Le Cras TD; Abman SH Effects of fumagillin and thalidomide treatment on alveolarization in the developing rat lung | 0 | 4 |
| 1103 | 0 | 0 | 1656 2000 BLOOD 96(11):294B-294B Rodriguez J; Oyama Y; Burt RK; Traynor AE Achievement of maximal disease response to thalidomide is limited by patient tolerance more often than disease resistance. | 0 | 4 |
| 1104 | 0 | 0 | 1674 2000 BLOOD 96(11):746A-746A Piccaluga PP; Finelli C; Ricci P; Cavo M; Pileri SA; Isidori A; Malagola M; Grafone T; Tura S; Visani G Antiangiogenic therapy with thalidomide improves anemia, thrombocytopenia, hyperleucocytosis, splenomegaly in idiopathic myelofibrosis. | 0 | 4 |
| 1105 | 0 | 0 | 1675 2000 BLOOD 96(11):746A-746A Barosi G; Grossi A; Comotti B; Marchetti M Thalidomide in patients with myelofibrosis with myeloid metaplasia. | 0 | 4 |
| 1106 | 12 | 33 | 1697 2000 CLINICAL INFECTIOUS DISEASES 30(5):826-831 Aboulafia DM Inflammatory pseudotumor causing small bowel obstruction and mimicking lymphoma in a patient with AIDS: Clinical improvement after initiation of thalidomide treatment | 1 | 4 |
| 1107 | 44 | 51 | 1733 2000 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 6(1):19-26 Lenardo TM; Calabrese LH The role of thalidomide in the treatment of rheumatic disease | 4 | 4 |
| 1108 | 17 | 19 | 1734 2000 JOINT BONE SPINE 67(4):259-261 Wendling D; Toussirot E; Michel F Thalidomide: a comeback? | 1 | 4 |
| 1109 | 1 | 1 | 1737 2000 JOURNAL OF CHILD NEUROLOGY 15(12):838-838 Schoeman JF Thalidomide therapy in childhood tuberculous meningitis | 3 | 4 |
| 1110 | 9 | 16 | 1756 2000 LIFE SCIENCES 66(2):133-141 Thiel R; Kastner U; Neubert R Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1111 | 3 | 7 | 1806 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(2):148-149 Esteve E; Legac E Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide | 4 | 4 |
| 1112 | 3 | 5 | 1814 2001 ARCHIVES OF INTERNAL MEDICINE 161(20):2502-2503 Rajkumar SV; Fonseca R; Witzig TE Complete resolution of reflex sympathetic dystrophy with thalidomide treatment | 3 | 4 |
| 1113 | 1 | 33 | 1825 2001 BIOMEDICAL CHROMATOGRAPHY 15(3):202-206 Duval R; Leveque H; Prigent Y; Aboul-Enein HY Enantioseparation of aminoglutethimide and thalidomide by high performance liquid chromatography or supercritical fluid chromatography on mono-2 and mono-6-O-pentenyl-beta-cyclodextrin-based chiral stationary phases | 1 | 4 |
| 1114 | 17 | 41 | 1827 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(5):1279-1291 Hess S; Akermann MA; Wnendt S; Zwingerberger K; Eger K Synthesis and immunological activity of water-soluble thalidomide prodrugs | 2 | 4 |
| 1115 | 0 | 0 | 1835 2001 BLOOD 98(11):161A-162A Zangari M; Siegel E; Anaissie E; Saghafifar F; Morris C; Fink L; Barlogie B; Tricot G Risk factors for deep vein thrombosis (DVT) in a large group of myeloma patients (pts) treated with thalidomide (Thal): The Arkansas experience. | 0 | 4 |
| 1116 | 0 | 0 | 1836 2001 BLOOD 98(11):162A-162A Palumbo A; Giaccone L; Bringhen S; Cavallo F; Falco P; Rus C; Bertola A; Pileri A; Boccadoro M Low dose thalidomide and dexamethasone are as effective as oral melphalan and prednisone in refractory and relapsed myeloma patients. | 0 | 4 |
| 1117 | 0 | 0 | 1839 2001 BLOOD 98(11):162A-163A Rajkumar SV; Dispenzieri A; Lacy M; Geyer S; Iturria N; Fonseca R; Hayman SR; Lust JA; Kyle R; Greipp PR; Gertz MA; Witzig TE Response rate and durablity of response with thalidomide therapy for relapsed multiple myeloma (MM). | 0 | 4 |
| 1118 | 9 | 12 | 1884 2001 BRITISH JOURNAL OF DERMATOLOGY 144(2):227-228 Allen BR Thalidomide | 4 | 4 |
| 1119 | 4 | 4 | 1886 2001 BRITISH JOURNAL OF DERMATOLOGY 144(6):1292-1293 Passeron T; Lacour JP; Murr D; Ortonne JP Thalidomide-induced amenorrhoea: two cases | 4 | 4 |
| 1120 | 3 | 4 | 1890 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(1):234-234 Myers B; Grimley C; Crouch D; Dolan G Lack of response to thalidomide in plasmacytomas | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1121 | 8 | 38 | 1895 2001 BRITISH JOURNAL OF PHARMACOLOGY 133(8):1414-1423 Lienenluke B; Stojanovic T; Fiebig T; Fayyazi A; Germann T; Hecker M Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat-role of endothelial cell-leukocyte interaction | 3 | 4 |
| 1122 | 10 | 46 | 1922 2001 ELECTROPHORESIS 22(15):3185-3190 Schoetz G; Trapp O; Schurig V Determination of the enantiomerization barrier of thalidomide by dynamic capillary electrokinetic chromatography | 1 | 4 |
| 1123 | 22 | 32 | 1960 2001 JOURNAL OF CLINICAL PHARMACOLOGY 41(6):662-667 Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD Thalidomide dose proportionality assessment following single doses to healthy subjects | 3 | 4 |
| 1124 | 5 | 29 | 1968 2001 JOURNAL OF NEURO-ONCOLOGY 55(1):11-17 Mawrin C; Aumann V; Kirches E; Schneider-Stock R; Scherlach C; Vogel S; Mittler U; Dietzmann K; Krause G; Weis S Gliomatosis cerebri: Post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide | 0 | 4 |
| 1125 | 24 | 55 | 1993 2001 OPHTHALMIC RESEARCH 33(5):256-263 Baatz H; Tonessen B; Prada J; Pleyer U Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis | 1 | 4 |
| 1126 | 16 | 18 | 2001 2001 REVUE DE MEDECINE INTERNE 22(1):5-7 Grosbois B; Duguet C Thalidomide: the revival | 2 | 4 |
| 1127 | 32 | 52 | 2014 2001 TOXICOLOGICAL SCIENCES 59(1):160-168 Teo SK; Evans MG; Brockman MJ; Ehrhart J; Morgan JM; Stirling DI; Thomas SD Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs | 4 | 4 |
| 1128 | 13 | 27 | 2022 2002 AMERICAN HEART JOURNAL 144(5):847-850 Gullestad L; Semb AG; Holt E; Skardal R; Ueland T; Yndestad A; Froland SS; Aukrust P Effect of thalidomide in patients with chronic heart failure | 1 | 4 |
| 1129 | 4 | 6 | 2032 2002 ANNALS OF ONCOLOGY 13(10):1636-1640 Grover JK; Uppal G; Raina V The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma | 3 | 4 |
| 1130 | 11 | 19 | 2052 2002 BJU INTERNATIONAL 89(6):591-595 Douglas ML; Reid JL; Hii SI; Jonsson JR; Nicol DL Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide | 1 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1131 | 0 | 0 | 2112 2002 BLOOD 100(11):403A-403A Hussein MA; Elson P; Tsoe EA; Karam M; Srkaloci G Doxil (D), vincristine (V), decadron (D) and thalidomide (T) (DVd-T) for relapsed/refractory multiple myeloma (RMM). | 0 | 4 |
| 1132 | 34 | 59 | 2126 2002 BLOOD REVIEWS 16(4):207-215 Strasser K; Ludwig H Thalidomide treatment in multiple myeloma | 3 | 4 |
| 1133 | 8 | 16 | 2158 2002 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 20(4):S43-S44 Seyahi E; Ozdogan H; Masatlioglu S; Yazici H Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient | 0 | 4 |
| 1134 | 90 | 130 | 2159 2002 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 20(5):709-718 Ossandon A; Cassara EAM; Priori R; Valesini G Thalidomide: focus on its employment in rheumatologic diseases | 2 | 4 |
| 1135 | 18 | 23 | 2195 2002 HAEMATOLOGICA 87(3):233-234 Tosi P; Cavo M Thalidomide in multiple myeloma: state of art | 3 | 4 |
| 1136 | 4 | 7 | 2196 2002 HAEMATOLOGICA 87(3):327-328 Corso A; Lorenzi A; Orlandi E; Astori C; Mangiacavalli S; Lazzarino M Advantages of using thalidomide for the management of patients with refractory myeloma | 3 | 4 |
| 1137 | 11 | 22 | 2204 2002 INTERNATIONAL IMMUNOPHARMACOLOGY 2(8):1143-1153 Shannon EJ; Sandoval FG Thalidomide can costimulate or suppress CD4(+) cells' ability to incorporate [H-3]-thymidine-dependence on the primary stimulant | 4 | 4 |
| 1138 | 18 | 24 | 2216 2002 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 767(1):145-151 Teo SK; Chandula RS; Harden JL; Stirling DI; Thomas SD Sensitive and rapid method for the determination of thalidomide in human plasma and semen using solid-phase extraction and liquid chromatography-tandem mass spectrometry | 3 | 4 |
| 1139 | 4 | 5 | 2222 2002 JOURNAL OF CLINICAL ONCOLOGY 20(8):2212-2212 Cany L; Fitoussi O; Boiron JM; Marit G Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma | 4 | 4 |
| 1140 | 13 | 21 | 2227 2002 JOURNAL OF COMBINATORIAL CHEMISTRY 4(2):149-153 Xiao ZL; Schaefer K; Firestine S; Li PK Solid-phase synthesis of thalidomide and its analogues | 0 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1141 | 5 | 24 | 2255 2002 LEUKEMIA & LYMPHOMA 43(1):133-137 Strupp C; Aivado M; Germing U; Gattermann N; Haas R Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports | 1 | 4 |
| 1142 | 7 | 24 | 2279 2002 PHARMACEUTICAL RESEARCH 19(1):13-19 Goosen C; Laing TJ; du Plessis J; Goosen TC; Flynn GL Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs | 4 | 4 |
| 1143 | 3 | 21 | 2280 2002 PHARMACEUTICAL RESEARCH 19(4):434-439 Goosen C; Laing TJ; du Plessis J; Goosen TC; Lu GW; Flynn GL Percutaneous delivery of thalidomide and its N-alkyl analogs | 3 | 4 |
| 1144 | 9 | 11 | 2286 2002 REVUE DE MEDECINE INTERNE 23(8):724-727 Gachon J; Grob JJ; Richard MA Thalidomide treatment leading thrombotic events: two cases | 3 | 4 |
| 1145 | 4 | 10 | 2419 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(2):305-308 Thompson MA; Witzig TE; Kumar S; Timm MM; Haug J; Fonseca R; Greipp PR; Lust JA; Rajkumar SV Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma | 2 | 4 |
| 1146 | 5 | 20 | 2440 2003 CLINICAL LYMPHOMA 4(1):32-35 Zangari M; Barlogie B; Thertulien R; Jacobson J; Eddleman P; Fink L; Fassas A; Van Rhee F; Talamo G; Lee CK; Tricot G Thalidomide and deep vein thrombosis in multiple myeloma: Risk factors and effect on survival | 1 | 4 |
| 1147 | 9 | 39 | 2496 2003 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 305(3):1222-1232 Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PPM; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs | 3 | 4 |
| 1148 | 10 | 14 | 2499 2003 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 48(4):548-552 Hall VC; El-Azhary RA; Bouwhuis S; Rajkumar SV Dermatologic side effects of thalidomide in patients with multiple myeloma | 3 | 4 |
| 1149 | 11 | 52 | 2501 2003 JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION 10(3):252-259 Weeber M; Vos R; Klein H; de Jong-van den Berg LTW; Aronson AR; Molema G Generating hypotheses by discovering implicit associations in the literature: A case report of a search for new potential therapeutic uses for thalidomide. | 0 | 4 |
| 1150 | 15 | 21 | 2547 2003 PHARMACOTHERAPY 23(3):315-318 Horne MK; Figg WD; Arlen P; Gulley J; Parker C; Lakhani N; Parnes H; Dahut WL Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1151 | 4 | 19 | 2563 2003 SYNTHETIC COMMUNICATIONS 33(8):1375-1382 Chang MY; Chen ST; Chang NC A synthesis of racemic thalidomide | 0 | 4 |
| 1152 | 0 | 0 | 2 1959 BRITISH MEDICAL JOURNAL 2(OCT3):635-635 DESOUZA LP THALIDOMIDE | 2 | 3 |
| 1153 | 0 | 0 | 16 1961 BRITISH MEDICAL JOURNAL 1(522):829-& SHAFAR J IS THALIDOMIDE TO BLAME | 2 | 3 |
| 1154 | 0 | 0 | 22 1961 BRITISH MEDICAL JOURNAL 2(525):1025-& CHEVENS LCF NEUROPATHY AFTER THALIDOMIDE | 2 | 3 |
| 1155 | 0 | 0 | 34 1961 BRITISH MEDICAL JOURNAL 2(526):1498-& KREMER M; FULLERTON PM NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 2 | 3 |
| 1156 | 3 | 6 | 69 1962 BRITISH MEDICAL JOURNAL (5305):646-& WARD SP THALIDOMIDE AND CONGENITAL ABNORMALITIES | 3 | 3 |
| 1157 | 0 | 0 | 105 1962 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 60(5):875-& FRANK O; ZEFFER H; LEEVY CM; BAKER H METABOLIC LESIONS INDUCED BY THALIDOMIDE | 2 | 3 |
| 1158 | 13 | 23 | 106 1962 JOURNAL OF PEDIATRICS 61(1):153-& BLATTNER RJ DRUGS IN PREGNANCY - THALIDOMIDE | 3 | 3 |
| 1159 | 6 | 9 | 157 1962 LIFE SCIENCES (7):333-336 SMITH RL; WILLIAMS RAD; WILLIAMS RT PHTHALOYLISOGLUTAMINE, A METABOLITE OF THALIDOMIDE | 2 | 3 |
| 1160 | 0 | 10 | 206 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):964-& HALL JE HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - SURGERY OF LIMB DEFECTS | 3 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1161 | 0 | 2 | 207 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):973-& GILPIN RE HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - PROSTHETIC ASPECTS | 3 | 3 |
| 1162 | 5 | 11 | 211 1963 CANCER CHEMOTHERAPY REPORTS (29):99-102 DIPAOLO JA EFFECT OF THALIDOMIDE ON A VARIETY OF TRANSPLANTABLE TUMORS | 0 | 3 |
| 1163 | 21 | 57 | 219 1963 HIROSHIMA JOURNAL OF MEDICAL SCIENCES 12(1):11-& TABUCHI A; SAWASAKI M; UMISA H; SHIRASUN.K; HORIKAWA M; YAMADA A; SHINTANI T PHOCOMELIA-LIKE DEFORMITY AND THALIDOMIDE PREPARATIONS | 3 | 3 |
| 1164 | 2 | 4 | 245 1963 MAYO CLINIC PROCEEDINGS 38(23):518-& WEIDMAN WH; YOUNG HH; ZOLLMAN PE EFFECT OF THALIDOMIDE ON UNBORN PUPPY | 5 | 3 |
| 1165 | 0 | 9 | 280 1964 COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES 158(4):737-& BERTRAND M; FLORIO R; DELATOUR P; MAGAT A SUR LA POTENTIALISATION DES EFFETS EMBRYOTOXIQUES DU THALIDOMIDE CHEZ LA RATTE | 2 | 3 |
| 1166 | 0 | 1 | 281 1964 EXPERIENTIA 20(5):283-& OBBINK HJK; DALDERUP LM EFFECTS OF THALIDOMIDE ON SKELETON OF RAT FOETUS | 2 | 3 |
| 1167 | 6 | 15 | 291 1964 MEDICINA EXPERIMENTALIS 11(2):119-& BERGSTROM RM; BERGSTROM L; PUTKONEN P; SAINIO K EFFECTS OF THALIDOMIDE ON ELECTRICAL ACTIVITY OF BRAIN IN INTRAUTERINE GUINEA-PIG FOETUS | 1 | 3 |
| 1168 | 5 | 14 | 295 1964 NATURE 204(496):939-& TATA JR THALIDOMIDE + INDUCED AMPHIBIAN METAMORPHOSIS | 2 | 3 |
| 1169 | 3 | 7 | 298 1964 POULTRY SCIENCE 43(2):506-& BOONE MA; BARNETT BD; HAMMOND M EFFECT OF THALIDOMIDE ON CHICKENS + EMBRYOS | 1 | 3 |
| 1170 | 0 | 0 | 310 1965 AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH 55(5):703-707 KELSEY FO PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961 | 1 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1171 | 0 | 0 | 379 1966 FEDERATION PROCEEDINGS 25(2P1):353-& SCHUMACHER H; GILLETTE J EMBRYOTOXIC EFFECTS OF THALIDOMIDE | 2 | 3 |
| 1172 | 0 | 4 | 388 1966 JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 195(8):695-& MATTHIES F TRIAD OF ANOTIA FACIAL PARALYSIS AND CARDIAC ANOMALY NOT DUE TO THALIDOMIDE | 0 | 3 |
| 1173 | 8 | 20 | 401 1966 LANCET 1(7451):1373-& CHARD T; HELLMANN K IMMUNOSUPPRESSION BY THALIDOMIDE | 3 | 3 |
| 1174 | 0 | 0 | 418 1967 ARZNEIMITTEL-FORSCHUNG 17(5):646-& BUELENS I TREATMENT WITH THALIDOMIDE OF AN ASTROCYTOMA OF SECOND DEGREE (N-PHTHALYGLUTAMIC ACID IMIDE) | 2 | 3 |
| 1175 | 2 | 5 | 421 1967 BIOCHEMICAL JOURNAL 103(1):P26-& FABRO S; HAGUE D; SMITH RL FATE OF [14C]THALIDOMIDE IN PREGNANT HAMSTER | 3 | 3 |
| 1176 | 0 | 0 | 435 1967 JOURNAL OF DENTAL RESEARCH 46(6P1S):1201-& KELSEY FO EVENTS AFTER THALIDOMIDE | 3 | 3 |
| 1177 | 0 | 0 | 509 1970 NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 266(4-5):408-& NEUBERT D; KOHLER E HYPOTHETICAL EXPLANATION OF EMBRYTOXIC ACTION OF THALIDOMIDE | 2 | 3 |
| 1178 | 8 | 31 | 530 1971 PEDIATRIC RESEARCH 5(5):199-& BERAN AV; STRAUSS J; SPERLING DR; NORTON AC; GARWOOD VP; YAMAZAKI J EFFECT OF THALIDOMIDE ON BRAIN OXYGENATION | 0 | 3 |
| 1179 | 14 | 26 | 531 1971 TERATOLOGY 4(1):75-& KELLER GR; BLAKE DA COMPARATIVE STUDIES ON ABSORPTION OF H-3 THALIDOMIDE IN RABBITS AND RATS | 1 | 3 |
| 1180 | 0 | 0 | 540 1972 ACTA PAEDIATRICA SCANDINAVICA 61(4):497-& SCHAFER KH SPASTIC HYPERTROPHIC PYLORIC STENOSIS AS EMBRYONAL MALFORMATION CAUSED BY THALIDOMIDE | 1 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1181 | 2 | 5 | 544 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):17-& JONSSON BG TERATOLOGICAL STUDIES ON THALIDOMIDE IN RABBITS | 0 | 3 |
| 1182 | 1 | 10 | 558 1972 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 140(1):167-& GELATO M; QUADRI SK; MEITES J INHIBITION OF PROLACTIN RELEASE BY A THALIDOMIDE-RELATED COMPOUND (CG 603) | 0 | 3 |
| 1183 | 0 | 2 | 589 1973 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 111(1):93-103 HUENGES E; IMMICH H; MARQUARD.E; ROMPE G; GRESSMAN.C; MAU H DOCUMENTATION AND REPORT ON THALIDOMIDE DAMAGE | 1 | 3 |
| 1184 | 0 | 11 | 594 1974 INTERNATIONAL JOURNAL OF HEALTH SERVICES 4(1):147-155 SCHIFRIN LG THALIDOMIDE AND BEYOND - SOME RECOMMENDATIONS REGARDING PUBLIC POLICIES TOWARD ETHICAL DRUG INDUSTRY | 0 | 3 |
| 1185 | 1 | 12 | 607 1974 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 112(3):408-411 GRESSMAN.C GROWTH IN LENGTH OF CHILDREN DAMAGED THROUGH THALIDOMIDE | 0 | 3 |
| 1186 | 7 | 19 | 617 1976 ARCHIV DER PHARMAZIE 309(1):62-69 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .7. METABOLISM AND ELIMINATION IN RAT OF THALIDOMIDE-LIKE COMPOUND K-2004 | 1 | 3 |
| 1187 | 3 | 5 | 621 1976 EXPERIENTIA 32(5):597-599 STOKES PA; LYKKE AWJ; MCBRIDE WG ULTRASTRUCTURAL CHANGES IN DORSAL ROOT-GANGLIA EVOKED BY THALIDOMIDE IN RABBITS | 0 | 3 |
| 1188 | 1 | 9 | 637 1977 ACTA PAEDIATRICA SCANDINAVICA 66(6):673-675 BROOK CGD; JARVIS SN; NEWMAN CGH LINEAR GROWTH OF CHILDREN WITH LIMB DEFORMITIES FOLLOWING EXPOSURE TO THALIDOMIDE INUTERO | 3 | 3 |
| 1189 | 3 | 14 | 641 1977 ARCHIVES OF TOXICOLOGY 37(2):165-172 JURECKA W; LASSMANN H; STOCKINGER L TERATOLOGIC-NEUROTOXIC EXAMINATION OF BIGLUMIDE (K-2004) AND THALIDOMIDE | 1 | 3 |
| 1190 | 0 | 1 | 656 1977 TERATOLOGY 15(2):A24-A24 THEISEN CT; HABIGER T; SWARTWOOD LD; SCHMIDT HL; WILSON JG THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - EVIDENCE FOR A PRIMARY EFFECT ON SPINAL GANGLIA | 1 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1191 | 5 | 16 | 663 1978 ARCHIV DER PHARMAZIE 311(9):779-785 PISCHEK G; FIEBRICH F; KOCH H THALIDOMIDE ANALOGS, .10. TRANSPLACENTAL DISTRIBUTION KINETICS OF BIGLUMIDE IN MOUSE | 0 | 3 |
| 1192 | 0 | 0 | 700 1979 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 47(2):381-382 SHANNON EJ; MIRANDA RO; HASTINGS RC EFFECT OF THALIDOMIDE ON DENOVO ANTIBODY-SYNTHESIS | 3 | 3 |
| 1193 | 0 | 0 | 711 1979 TERATOLOGY 19(2):A51-A51 THEISEN CT; SPENCER MP MORPHOLOGICAL OBSERVATIONS IN RHESUS-MONKEY EMBRYOS FOLLOWING MATERNAL THALIDOMIDE ADMINISTRATION | 2 | 3 |
| 1194 | 3 | 4 | 798 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(6-7):551-552 NOUGUE J; NOUGUE M; BAZEX J; HAYEK JP; BIDOUZE H OCCURRENCE OF A GENITAL HEMORRHAGIC DURING A THALIDOMIDE TREATED PRURIGO NODULARIS | 3 | 3 |
| 1195 | 6 | 17 | 802 1983 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 16(2):105-109 SCHMIDT M; SALZANO FM CLINICAL-STUDIES ON TEENAGE BRAZILIAN VICTIMS OF THALIDOMIDE | 2 | 3 |
| 1196 | 0 | 0 | 816 1983 CLINICAL RESEARCH 31(5):A920-A920 DOLL NJ; BARNHILL RL; HASTINGS RC; SALVAGGIO JE; MILLIKAN LE THALIDOMIDE INDUCED ALTERATION OF HUMAN PERIPHERAL-BLOOD MONOCYTE ACTIVITY | 3 | 3 |
| 1197 | 0 | 6 | 833 1983 TERATOLOGY 27(2):A29-A30 BECK SL PAUCITY OF POSTNATAL EFFECTS ON CD-1 MOUSE SKELETON OF PRENATAL EXPOSURE TO CAPTAN, THALIDOMIDE, CORTISONE, OR DIPHENYLHYDANTOIN | 0 | 3 |
| 1198 | 1 | 10 | 897 1985 LANCET 1(8423):288-289 LEHNER T; SULLIVAN FM THALIDOMIDE, OROGENITAL ULCERS, AND THE RISK OF TERATOGENESIS | 1 | 3 |
| 1199 | 1 | 2 | 898 1985 LANCET 1(8427):511-511 JENKINS S; POWELL RJ; ALLEN BR; LITTLEWOOD S; MAURICE PD; SMITH NJ THALIDOMIDE, OROGENITAL ULCERS, AND RISK OF TERATOGENICITY | 2 | 3 |
| 1200 | 7 | 11 | 968 1988 FUNDAMENTAL & CLINICAL PHARMACOLOGY 2(6):493-497 DESCOTES J; TEDONE R; EVREUX JC ENHANCEMENT OF ANTIBODY-RESPONSE AND DELAYED-TYPE HYPERSENSITIVITY BY THALIDOMIDE IN MICE | 3 | 3 |
Page 4: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22